[go: up one dir, main page]

WO2008042841A3 - Docetaxel compositions - Google Patents

Docetaxel compositions Download PDF

Info

Publication number
WO2008042841A3
WO2008042841A3 PCT/US2007/080063 US2007080063W WO2008042841A3 WO 2008042841 A3 WO2008042841 A3 WO 2008042841A3 US 2007080063 W US2007080063 W US 2007080063W WO 2008042841 A3 WO2008042841 A3 WO 2008042841A3
Authority
WO
WIPO (PCT)
Prior art keywords
docetaxel
compositions
docetaxel compositions
dilution
emulsion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/080063
Other languages
French (fr)
Other versions
WO2008042841A2 (en
Inventor
Kocherlakota Chandrasekhar
Tarun Singh
Bejgum Santosha
Banda Nagaraju
Ramesh Mullangi
Ravi Kumar Trivedi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Original Assignee
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Ltd, Dr Reddys Laboratories Inc filed Critical Dr Reddys Laboratories Ltd
Publication of WO2008042841A2 publication Critical patent/WO2008042841A2/en
Publication of WO2008042841A3 publication Critical patent/WO2008042841A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Emulsion-preconcentrate compositions comprising docetaxel, processes for preparing the same, and their methods of use. The docetaxel compositions are suitable for parenteral administration to treat neoplasm conditions, upon dilution with aqueous fluids.
PCT/US2007/080063 2006-10-02 2007-10-01 Docetaxel compositions Ceased WO2008042841A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82772806P 2006-10-02 2006-10-02
US60/827,728 2006-10-02

Publications (2)

Publication Number Publication Date
WO2008042841A2 WO2008042841A2 (en) 2008-04-10
WO2008042841A3 true WO2008042841A3 (en) 2008-10-02

Family

ID=39269137

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/080063 Ceased WO2008042841A2 (en) 2006-10-02 2007-10-01 Docetaxel compositions

Country Status (1)

Country Link
WO (1) WO2008042841A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009280803B2 (en) 2008-07-23 2013-10-31 Bharat Serums And Vaccines Ltd. Stable injectable oil-in-water Docetaxel nanoemulsion
FR2934955B1 (en) * 2008-08-14 2011-07-08 Commissariat Energie Atomique ENCAPSULATION OF LIPOPHILIC OR AMPHIPHILIC THERAPEUTIC AGENTS IN NANOEMULSIONS
US8476310B2 (en) 2009-10-19 2013-07-02 Scidose Llc Docetaxel formulations with lipoic acid
US7772274B1 (en) 2009-10-19 2010-08-10 Scidose, Llc Docetaxel formulations with lipoic acid
US8912228B2 (en) 2009-10-19 2014-12-16 Scidose Llc Docetaxel formulations with lipoic acid
CN101926757B (en) * 2010-09-01 2013-01-02 北京大学 Liquid composition of indissolvable medicines and preparation method thereof
US20140105829A1 (en) * 2012-10-15 2014-04-17 Nemucore Medical Innovations, Inc. Therapeutic nanoemulsion formulation for the targeted delivery of docetaxel and methods of making and using the same
FR3052360B1 (en) * 2016-06-10 2019-11-01 Friulchem SELF-EMULSITIVE LIPID COMPOSITIONS
CN117177737A (en) * 2023-05-06 2023-12-05 北京德立英捷医药科技有限公司 Self-emulsifiable docetaxel injection composition and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050004002A1 (en) * 2002-12-09 2005-01-06 American Bioscience, Inc. Compositions and methods of delivery of pharmacological agents
US20050232952A1 (en) * 2002-03-01 2005-10-20 Gregory Lambert Self emulsifying drug delivery systems for poorly soluble drugs
US20060034770A1 (en) * 2003-02-04 2006-02-16 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
US20060067952A1 (en) * 2004-09-28 2006-03-30 Sd Pharmaceuticals, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050232952A1 (en) * 2002-03-01 2005-10-20 Gregory Lambert Self emulsifying drug delivery systems for poorly soluble drugs
US20050004002A1 (en) * 2002-12-09 2005-01-06 American Bioscience, Inc. Compositions and methods of delivery of pharmacological agents
US20060034770A1 (en) * 2003-02-04 2006-02-16 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
US20060067952A1 (en) * 2004-09-28 2006-03-30 Sd Pharmaceuticals, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs

Also Published As

Publication number Publication date
WO2008042841A2 (en) 2008-04-10

Similar Documents

Publication Publication Date Title
WO2008042841A3 (en) Docetaxel compositions
WO2010108108A3 (en) Polyamine derivatives
WO2012058211A3 (en) Quinazoline derivatives, compositions, and uses related thereto
WO2009089494A3 (en) Pharmaceutical compositions
WO2009129246A3 (en) Compositions and methods for preparing and using same
WO2007126824A3 (en) Methods and systems for sterilization
WO2012100224A3 (en) Preparation of metal-triazolate frameworks
WO2010151541A8 (en) Polymorphic form d of bazedoxifene acetate and methods of preparing same
WO2007086001A3 (en) Novel pyridine derivatives
WO2011142858A3 (en) Chlorotoxin variants, conjugates, and methods for their use
WO2007149907A3 (en) Pyrazoloquinazolinones as parp inhibitors
WO2012116010A3 (en) Antibiotic tolerance inhibitors
WO2011056511A3 (en) 4,6-diaminopyrimidine stimulators of soluble guanylate cyclase
WO2011133504A3 (en) Nanozymes, methods of making nanozymes, and methods of using nanozymes
WO2013003669A3 (en) Compositions, methods of use, and methods of treatment
WO2008027600A3 (en) Imatinib compositions
WO2013034979A3 (en) Crystalline forms of cabazitaxel
WO2011160024A3 (en) Compounds useful as antiviral agents, compositions, and methods of use
WO2012158672A3 (en) Compounds for use in treatment of mucositis
EA201200934A1 (en) ANTI-TRACT COMBINATIONS OF MEDICINES BASED ON ARTHEMISININE WITH OTHER CHEMOTHERAPEUTIC AGENTS
WO2012024350A3 (en) Anti-cancer adenoviruses
MY161601A (en) Films and compositions comprising the same
WO2012087327A3 (en) Polymer systems
WO2009094457A3 (en) Substituted benzhydrylethers
WO2009002538A3 (en) Amorphous erlotinib, processes for the preparation thereof, and processes to prepare additional forms of erlotinib

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07853708

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07853708

Country of ref document: EP

Kind code of ref document: A2